Sustained Disease Control in Transplant-Ineligible Patients: The Role of Continuous Therapy

Leukemia Research- United Kingdom

doi 10.1016/s0145-2126(12)70005-x

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Treatment-Free Interval as an Additional Measure of Efficacy in a Large UK Dataset of Transplant Ineligible Myeloma Patients

PLoS ONE
Multidisciplinary
2020English

Front-Line Therapies for Elderly Patients With Transplant-Ineligible Multiple Myeloma and High-Risk Cytogenetics in the Era of Novel Agents

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

The Role of Macrophage Cytophilic Antibiodies in Kidney Transplant Patients.

Keio Journal of Medicine
Medicine
1975English

Renal Anaemia: The Role of Haemoglobin Control in Patients With Chronic Kidney Disease

Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences
Multidisciplinary
2010English

Individualized Immunosuppression in Transplant Patients: Potential Role of Pharmacogenetics

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2012English

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase Beta Therapy in Patients With Fabry Disease

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2007English

Music Therapy for the Hematopoietic Stem Cell Transplant Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin‐Ineligible Patients With Muscle‐Invasive Localized Urothelial Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Bortezomib-Based Induction for Transplant Ineligible AL Amyloidosis and Feasibility of Later Transplantation

Bone Marrow Transplantation
TransplantationHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy